PT  - JOURNAL ARTICLE
AU  - A. G. NANNINGA
AU  - P.H.B. WILLEMSE
AU  - E.G.E. DE VRIES
AU  - H. BOONSTRA
TI  - Low complication rate during intraperitoneal therapy through a totally implanted peritoneal access port in patients with ovarian cancer
AID  - 10.1046/j.1525-1438.1992.02020107.x
DP  - 1992 Mar 01
TA  - International Journal of Gynecologic Cancer
PG  - 107--110
VI  - 2
IP  - 2
4099  - http://ijgc.bmj.com/content/2/2/107.short
4100  - http://ijgc.bmj.com/content/2/2/107.full
SO  - Int J Gynecol Cancer1992 Mar 01; 2
AB  - Fifty-three patients with histologically proven ovarian cancer were treated with intraperitoneally administered cisplatin or human recombinant interferon-alpha through a totally implanted peritoneal access port. A total of 281 treatment courses were given. No complications related to surgical implantation of the port were seen. Infectious complications, intra-abdominal problems or subcutaneous drug extravasation did not occur. In two patients the number of treatment courses was limited due to inflow obstruction. A totally implanted peritoneal access port proves to be a reliable route for the intraperitoneal treatment of patients with ovarian cancer. The strict aseptic technique we used contributes to its safety by preventing intra-abdominal infections.